12:00 AM
Apr 19, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

BC-3781: Phase I data

In a double-blind, placebo-controlled, dose-escalating Phase I trial in 12 healthy subjects, BC-3781 was well-tolerated and produced no clinically...

Read the full 73 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >